Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 418M | 409M | 440M | 436M |
Cost of revenue | 170M | 166M | 174M | 171M |
Gross profit | 248M | 243M | 266M | 265M |
Operating expense | ||||
Research & development | 66M | 68M | 73M | 68M |
Selling general and admin | 116M | 136M | 137M | 131M |
Other operating expenses | — | — | — | — |
Operating income | 66M | 39M | 56M | 66M |
Non operating interest income | ||||
Income | 3M | 2M | 3M | 2M |
Expense | 7M | 7M | 7M | 7M |
Other income expense | -4M | -4M | -5M | -6M |
Pretax income | 58M | 30M | 47M | 55M |
Tax provision | 14M | 5M | 15M | 18M |
Net income | 44M | 25M | 32M | 37M |
Basic EPS | 0.5 | 0.3 | 0.3 | 0.4 |
Diluted EPS | 0.5 | 0.3 | 0.3 | 0.4 |
Basic average shares | 95.1M | 95.5M | 96.1M | 96.5M |
Diluted average shares | 97.4M | 97.4M | 97M | 97.4M |
EBITDA | 85M | 60M | 79M | 90M |
Net income from continuing op. | 44M | 25M | 32M | 37M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |